NUFARM LIMITED — Capital/Financing Update 2017

Nov 19, 2017

NOT FOR RELEASE OR DISTRIBUTION IN THE UNITED STATES

COMPANY ANNOUNCEMENT

20 November 2017

Nufarm successfully completes retail entitlement offer

• The Retail Entitlement Offer has closed, with approximately A$85 million in applications received

• Approximately A $ 26 million retail Entitlements will be offered under the Retail Shortfall Bookbuild, expected to commence after market close today (Monday, 20 October 2017)

Nufarm Limited ("Nufarm") today announced the successful completion of the retail component ("Retail Entitlement Offer") of its fully underwritten 2 for 9 pro rata accelerated renounceable entitlement offer with retail rights trading ("Entitlement Offer"). The Retail Entitlement Offer was well supported by eligible Nufarm retail shareholders, raising gross proceeds of approximately A$85 million.

Completion of the Retail Entitlement Offer represents the second stage of Nufarm’s approximately A$446 million equity raising, announced on Tuesday, 24 October 2017. The institutional component of the entitlement offer (including the Institutional Shortfall Bookbuild) closed on Thursday, 26 October 2017, raising gross proceeds of A$338 million.

Summary of the Retail Entitlement Offer

• A$85 million in applications under the Retail Entitlement Offer were received

• 77% of available retail entitlements were taken-up under the Retail Entitlement Offer

The Retail Entitlement Offer attracted strong demand, with Nufarm receiving valid acceptances in respect of A$85 million New Shares, representing 77% of New Shares available under the Retail Entitlement Offer.

Retail Shortfall Bookbuild

Approximately A$26 million retail entitlements, representing entitlements not taken up by eligible retail shareholders and the entitlements of ineligible retail shareholders, will be offered for sale for the benefit of those shareholders in a retail shortfall bookbuild (“Retail Shortfall Bookbuild”).

The Retail Shortfall Bookbuild will be conducted after market close on Monday, 20 November 2017.

==> picture [596 x 7] intentionally omitted <==

Page 1 of 3

==> picture [594 x 112] intentionally omitted <==

The settlement date for New Shares to be issued under the Retail Entitlement Offer and the Retail Shortfall Bookbuild is expected to be Thursday, 23 November 2017. New Shares are expected to be issued on Friday, 24 November 2017 and commence trading on the ASX on Monday, 27 November 2017.

-- end --

Further information: Mark Keating General Manager, Investor Relations mark.keating@nufarm.com  (61 3) 9282 1004  0419 545 144

Megan Fletcher Group Executive, Corporate Affairs megan.fletcher@nufarm.com  (61 3) 9282 1218  0428 139 531

NOT FOR RELEASE OR DISTRIBUTION IN THE UNITED STATES

This announcement has been prepared for publication in Australia and may not be released or distributed in the United States. This announcement does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States or any other jurisdiction in which such an offer would be illegal. Any Entitlements or securities described in this announcement have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (“US Securities Act”) or the securities laws of any state or other jurisdiction of the United States. Accordingly, no securities described in this announcement may be offered, sold or resold, directly or indirectly, in the United States or to a person acting for the account or benefit of a person in the United States, unless they have been registered under the U.S. Securities Act (for which Nufarm has no obligation to do or procure), or are offered, sold or resold in a transaction exempt from, or not subject to, the registration requirements of the US Securities Act and any applicable US state securities laws.

Forward looking statements

This announcement contains forward looking statements, including statements of current intention, statements of opinion and predictions as to possible future events. Forward looking statements can generally be identified by the use of forward looking words such as “believe”, "forecast", "projection", “expect”, “estimate”, “will”, “may”, “target”, "anticipate", "likely", "intend", "should", "could", "predict", "plan", "propose", "potential" and other similar expressions within the meaning of securities laws of applicable jurisdictions, and include but are not limited to the expected outcome of the acquisition of products from Adama and Syngenta. Indications of, and guidance or outlook on, future earnings or financial position or performance are also forward looking statements. Such statements are not statements of fact and there can be no certainty of outcome in relation to

==> picture [596 x 7] intentionally omitted <==

Page 2 of 3

==> picture [594 x 112] intentionally omitted <==

the matters to which the statements relate. These forward looking statements involve known and unknown risks, uncertainties, assumptions and other important factors that could cause the actual outcomes to be materially different from the events or results expressed or implied by such statements. Those risks, uncertainties, assumptions and other important factors are not all within the control of Nufarm, cannot be predicted by Nufarm and include changes in circumstances or events that may cause objectives to change as well as risks, circumstances and events specific to the industry, countries and markets in which Nufarm operates. They also include, without limitation, general economic conditions, exchange rates, interest rates, competitive pressures, selling price, market demand and conditions in the financial markets which may cause objectives to change or may cause outcomes not to be realised.

None of Nufarm or any of its subsidiaries, advisors or affiliates (or any of their respective officers, employees or agents) makes any representation, assurance or guarantee as to the accuracy or likelihood of fulfilment of any forward looking statement or any outcomes expressed or implied in any forward looking statements. Statements about past performance are not necessarily indicative of future performance.

==> picture [596 x 7] intentionally omitted <==

Page 3 of 3